FKBP12, also known as the 12 kDa FK506-binding protein, is a member of the immunophilin protein family. These proteins have peptidyl-prolyl cis-trans isomerase (PPIase) activity, which plays a pivotal role in protein folding. The FKBP12 protein has been extensively studied due to its strong affinity for specific ligands, such as FK506 and rapamycin. FKBP12 activators are chemical compounds that augment the activity or modulate the function of FKBP12. These activators can specifically bind to FKBP12, thus enhancing its innate functions.
The chemical structures of FKBP12 activators can vary widely. Given that FKBP12 has a specific, high-affinity binding pocket, activators often possess structural motifs or domains that can readily and specifically interact with this region. These motifs ensure selectivity and potency in binding and activation. Moreover, the interaction between FKBP12 and its activators can be influenced by factors such as the environment of the binding pocket, the overall configuration of the protein, and the dynamic conformational changes FKBP12 might undergo upon ligand binding. FKBP12 activators have opened a new dimension in the study of protein-protein and protein-ligand interactions, expanding our understanding of the intricate biochemical processes within cells. As the knowledge about these activators deepens, there is a growing appreciation for their nuanced mechanisms of action and their influence on FKBP12 functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ascomycin | 104987-12-4 | sc-207303B sc-207303 sc-207303A | 1 mg 5 mg 25 mg | $37.00 $176.00 $322.00 | ||
A macrolide closely related to tacrolimus. While it binds to FKBP12, it is less immunosuppressive than FK506. | ||||||
Zotarolimus | 221877-54-9 | sc-213188 | 1 mg | $240.00 | ||
A derivative of sirolimus, it's used to provide thrapeutic properties helping with arterial restenosis. | ||||||